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ABSTRACT
Aims: To identify potential contaminants of the
corneal sampling procedure and examine the effect of
wearing surgical face masks on the rate of
contamination.
Methods: Ten surgeons recited out loud a 30 s
standardised script for corneal scraping with blood
agar plates positioned 30 cm away from them. Three
groups were identified: in group 1 a surgical mask was
worn; group 2 had no mask worn; and group 3 had no
mask but used agar plates pretreated with 5%
povidone-iodine as a negative control. Each surgeon
repeated the process 10 times for all groups, totalling
30 plates per surgeon and 300 plates for the
experiment. All plates were masked and incubated
aerobically at 37C for 24 hours, and the number of
colony forming units (CFUs) was determined.
Results: At 24 hours, group 1 had a mean of 0.3
CFUs per surgeon; group 2 had 6.4 CFUs per surgeon
and group 3 had 0.1 CFUs per surgeon. The difference
between group 1 and group 2 was significant
(p<0.001) whereas the difference between group 1 and
group 3 was non-significant (p=0.4). Use of face
masks decreased the number of plates with CFUs by
93% (from 29 to 2 plates) and decreased the total
number of CFUs by 95% (from 63 to 3 CFUs). The
most common microbiota identified was Streptococcus
species.
Conclusions: Oral bacterial microbiota may
contaminate the slides and media used to collect
samples during corneal sampling. Use of a face mask
can significantly decrease the rate of contamination of
such samples.
INTRODUCTION
Corneal tissue sampling for microscopy
and culture is the gold standard for iden-
tifying the causative organisms in
microbial keratitis.1 Accurate diagnosis is
needed as visual loss can occur rapidly
and significant morbidity is associated with
chronic disease. Further, a diversity of
species has been implicated.2 Corneal
sampling, however, does not always yield
reliable results3 4; the reported culture
positivity rate ranges from 25% to 78%,5 6
and false positives and negatives occur.
Improved diagnosis of keratitis is needed
because it is a significant and increasing
cause of visual loss worldwide3 7 8; it was
estimated that over 1.5 million people
worldwide developed corneal ulceration
annually and its prevalence is rising with
the increased use of contact lenses.9–11
The reliability of corneal sampling may be
compromised by contamination of the spec-
imen. This can reduce the diagnostic value
of the scrape resulting in delayed or inap-
propriate therapy.12 Methods to reduce
contamination during corneal scraping have
not been investigated. Recently, a simple
experimental study identified that the use
of surgical face masks significantly
decreased the dispersion of bacteria that
can contaminate the surgical field during
intravitreal injections, leading to its wide-
spread adoption to decrease contamination
risk.13 Currently, masks are not routinely
worn for corneal scraping.
Key messages
What is known?
" Corneal sampling is the gold standard for
diagnosing microbial keratitis, though the
culture positivity rate can be highly variable
with reports ranging from 25% to 78%.
" Contaminants reduce the diagnostic value of
corneal sampling and can delay appropriate
treatment.
What are the new findings?
" Oral microbiota can contaminate agar plates.
" The use of face masks decreased the number
of plates with colony forming units (CFUs) by
93% and decreased the total number of CFUs
by 95%.
How might these results change the focus of clinical
practice?
" Wearing a face mask is a low-cost and no harm
method that significantly decreased
contamination rates and may potentially
improve the reliability of the results obtained
from corneal samples in microbial keratitis.
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Because of the lack of evidence on the role of face
masks in reducing contamination of the collected
samples in microbial keratitis, we performed a prospec-
tive experimental study. In this study,
ophthalmologists and ophthalmology trainees re-
enacted the corneal scraping procedure with and
without a face mask. The purpose was to examine the
effect of wearing a face mask on bacterial microbiota
counts cultured on agar plates during an experimental
corneal scrape procedure.
METHODS
Experimental structure
A total of 10 ophthalmologists or ophthalmology
trainees participated in the experiment. Each
surgeon read out loud a standardised script lasting
30 se c o n d s with a horizontally positioned blood
agar plate 30 cm from their mouth. The script and
position of the agar plates were determined via
consultation with ophthalmologists and trainees who
regularly perform corneal scrapes and reflect the
length of dialogue required to give instructions to
patients and location of the slides and media used to
collect samples during the procedure. To mimic clin-
ical practice during a scrape, plate lids were
removed just prior to inoculation and replaced
immediately afterwards. The experiment was
conducted in our ophthalmology emergency depart-
ment where corneal scrapes are routinely performed.
Each surgeon repeated the procedure 10 times for
all groups. In group 1, a standard surgical mask
(Livingstone Premium Surgical Face Mask, Living-
stone International, Australia) was worn. In group 2
no mask was worn. Group 3 had no mask and used
agar plates pretreated with 5% povidone-iodine
(Betadine 5% Sterile Ophthalmic Prep Solution,
Alcon, USA) to act as a negative control. In total,
300 plates (100 for each group) were collected. The
plates were incubated aerobically at 37C for 24
hours, after which the number of bacterial colony
forming units (CFUs) on each plate was counted.
The plates were labelled numerically and laboratory
staff were masked to prevent bias.
Identification of organisms
See online supplementary material. In brief, different
colony morphotypes from the agar plates were isolated
and the identification of bacteria was conducted by
sequencing the 16S rRNA gene from each colony
morphotype.
Power calculation and statistical analysis
A power calculation was performed prior to the experi-
ment that determined that 100 plates per category
exceeded the number needed to detect a difference in
mean CFUs per group of 0.5 at a power of 0.95. The
Mann-Whitney U test for non-parametric testing was
used to determine the significance of the difference
between means per group.
RESULTS
All 300 plates were successfully incubated. Strepto-
coccus species were the most frequently identified
bacteria. Table 1 demonstrates the difference in
means between groups. Group 1 (mask) had a mean
Table 1 Characteristics between groups
Group 1
(Mask)
Group 2
(No mask)
Group 3
(Povidone-
iodine)
Mean CFUs per
surgeon
0.3 6.4 0.1
SD 0.3 1.2 0.1
Statistical
comparison
with group 1
p<0.001 p=0.4
CFUs, colony forming units.
Figure 1 Histogram of number
of colony forming units (CFUs)
after 24 hours of incubation
between group 1 and group 2.
There was a 95% reduction in
CFUs with the use of a surgical
face mask.
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of 0.3 CFUs per surgeon; group 2 (no mask) had a
mean of 6.4 CFUs; and group 3 (povidone-iodine)
had a mean of 0.1 CFUs. There was a significant
difference between group 2 and the other groups
(p<0.001), and no difference between group 1 and
group 3 (p=0.4).
Figure 1 demonstrates the difference in the number
of CFUs isolated after 24 hours between group 1 and
group 2. Use of a face mask decreased the number of
plates with CFUs by 93% (from 29 to 2 plates) and
decreased the total number of CFUs by 95% (from 63
to 3 CFUs).
Table 2 shows the different bacterial organisms
isolated. Group 1 had 3 bacterial CFUs identified
whereas group 3 had only 1 isolate. In contrast, group
2 had 63 bacterial CFUs identified, predominantly
from respiratory microbiota.
DISCUSSION
Our study shows that wearing a surgical mask decreases
the risk of agar plate contamination during an experi-
mental corneal scrape scenario. We found that the
spread of respiratory and skin microbiota was reduced
by a factor of 21; the number of plates contaminated
was reduced by 93% and the total number of CFUs was
reduced by 95%. The use of a face mask was found to
approximate the antiseptic properties of povidone-
iodine in its effect on bacterial CFUs.
Recognising organisms that are potential contami-
nants is clinically important. Bacterial keratitis is
most commonly caused by members of the coagulase
negative staphylococci, Staphylococcus aureus, or if
contact lenses have been worn, Pseudomonas aerugi-
nosa.11 14 15 Microbiology laboratories use various
clues to identify possible contaminant bacteria. The
normal ocular microbiota is composed predominantly
of coagulase negative staphylococci, Corynebacterium
sp and Propionibacterium sp. Streptococci are very occa-
sionally isolated from normal eyes (<1%–3.7%) and
can be isolated from cases of keratitis, but their pres-
ence in clinical samples is not common and so
should be treated as potential contaminants unless in
high numbers and isolated on most media used.16–19
In the scenario of progressive keratitis, differenti-
ating pathogenic organisms from contaminants will
potentially alter treatment. Our study identified Strepto-
coccus, Micrococcus, Staphylococcus and Bacillus species as
potential contaminants. This correlates with another
study that identified these species as more likely to be
cultured from broth than agar media, which is a
common finding in contaminants.19 Our results high-
light that oral microbiota when identified from corneal
samples could be contaminants and should be consid-
ered in progressive keratitis, triggering the clinician to
repeat the corneal sampling to identify the causal
organism. Further, we identified Streptococcus species as
the the most common bacteria cultured. This is clini-
cally significant as these bacteria have a different
antibiotic resistance profile to many Gram-positive
organisms,19 20 meaning that an incorrect diagnosis
may delay treatment and potentially lead to avoidable
loss of visual acuity.
Our study is a prospective masked study with large
numbers. However, it is limited by the standardised
techniques used. In clinical practice, an individual
surgeon would hold the agar plate at a variable
distance and would talk for a variable duration, if any.
We obtained consensus from clinicians at our hospital
in designing this study to align the study procedures
with those in clinical practice.
In conclusion, our study confirmed that oral micro-
biota can contaminate agar plates placed in the field
during a re-enactment of the corneal sampling proce-
dures. In a busy clinical setting where not speaking
cannot be guaranteed, wearing a face mask is a low-
cost and no harm method that significantly decreased
contamination rates and may potentially improve the
reliability of the results obtained from corneal samples
in microbial keratitis.
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Table 2 Bacterial isolates from each group
Group 1
(Mask)
Group 2
(No mask)
Group 3
(Povidone-iodine)
Respiratory microbiota
Streptococci spp 2 51 1
Skin microbiota
Micrococcus spp 1 6 0
Staphylococcus spp 0 4 0
Bacillus spp 0 2 0
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